We are live on ! Find out more
MIM

Monashee Investment Management Portfolio holdings

AUM $184M
1-Year Est. Return 197.43%
This Fund
S&P 500
This Quarter Est. Return
+0.64%
1 Year Est. Return
+197.43%
3 Year Est. Return
+447.04%
5 Year Est. Return
+479.31%
10 Year Est. Return
+5,610.42%
AUM
$650M
AUM Growth
-$107M
Cap. Flow
-$73.7M
Cap. Flow %
-11.34%
Top 10 Hldgs %
28.5%
Holding
529
New
249
Increased
8
Reduced
22
Closed
155

Top Buys

Rank Stock Value
1
BEAM icon
Beam Therapeutics
BEAM
+$25.6M
2
PSFE icon
Paysafe
PSFE
+$12.2M
3
VIEW
View, Inc. Class A Common Stock
VIEW
+$11.9M
4
OUST icon
Ouster
OUST
+$9.91M
5
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$8.09M

Top Sells

Rank Stock Value
1
VTI icon
Vanguard Morningstar Total Stock Market ETF
VTI
+$53.1M
2
SGTX
Sigilon Therapeutics, Inc. Common Stock
SGTX
+$27M
3
QTRX icon
Quanterix
QTRX
+$20.3M
4
SPRU icon
Spruce Power Holding Corp
SPRU
+$14.9M
5
SNRHU
Senior Connect Acquisition Corp. I Unit
SNRHU
+$10.3M

Sector Composition

Rank Sector Weight
1 Healthcare 27.3%
2 Financials 11.86%
3 Technology 7.97%
4 Industrials 4.89%
5 Communication Services 3.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ICHR icon
401
Ichor Holdings
ICHR
$2.43B
– –
-40,000
Closed -$1.21M
IQ icon
402
iQIYI
IQ
$1.31B
– –
-20,000
Closed -$350K
KPLT icon
403
Katapult Holdings
KPLT
$31.6M
– –
-4,000
Closed -$1.25M
KURA icon
404
Kura Oncology
KURA
$874M
– –
-115,000
Closed -$3.76M
LPRO
405
DELISTED
Open Lending Corp
LPRO
– –
-25,000
Closed -$874K
MAPSW
406
DELISTED
WM TECHNOLOGY INC WTS
MAPSW
– –
-31,957
Closed -$105K
MAPS
407
DELISTED
WM TECHNOLOGY INC A
MAPS
– –
-200,000
Closed -$2.55M
MIR icon
408
Mirion Technologies
MIR
$3.75B
– –
-200,000
Closed -$2.18M
MIRM icon
409
Mirum Pharmaceuticals
MIRM
$6.02B
– –
-125,000
Closed -$2.18M
MRVI icon
410
Maravai LifeSciences
MRVI
$895M
– –
-360,000
Closed -$10.1M
NBTX
411
Nanobiotix
NBTX
$1.84B
– –
-15,000
Closed -$248K
NFE icon
412
New Fortress Energy
NFE
$97.8M
– –
-50,000
Closed -$2.68M
NIO icon
413
NIO
NIO
$12.1B
– –
-125,000
Closed -$6.09M
NTLA icon
414
Intellia Therapeutics
NTLA
$1.68B
– –
-25,000
Closed -$1.36M
OBIO icon
415
Orchestra BioMed
OBIO
$267M
– –
-100,000
Closed -$1.28M
OCUL icon
416
Ocular Therapeutix
OCUL
$2.03B
– –
-60,000
Closed -$1.24M
OM icon
417
Outset Medical
OM
$91.4M
– –
-4,000
Closed -$3.41M
ONDS icon
418
Ondas Inc
ONDS
$5.31B
– –
-30,000
Closed -$280K
PACB icon
419
Pacific Biosciences
PACB
$357M
– –
-60,000
Closed -$1.56M
PRCH icon
420
Porch Group
PRCH
$1.75B
– –
-600,000
Closed -$8.56M
PTGX icon
421
Protagonist Therapeutics
PTGX
$9.71B
– –
-70,000
Closed -$1.41M
REPL icon
422
Replimune Group
REPL
$1.15B
– –
-25,000
Closed -$954K
REXR icon
423
Rexford Industrial Realty
REXR
$8.13B
– –
-75,000
Closed -$3.68M
RKLB icon
424
Rocket Lab Corp
RKLB
$50B
– –
-199,998
Closed -$2.29M
RPRX icon
425
Royalty Pharma
RPRX
$25.8B
– –
-120,000
Closed -$6.01M
15 16
17
18 19

Similar funds

SWMG
Sard Wealth Management Group Atlanta, Georgia $184M AUM 11.26% 1-Year Est. Return
IFPL
Investments & Financial Planning LLC Lexington, Kentucky $184M AUM 17.7% 1-Year Est. Return
RFG
RFP Financial Group Atlanta, Georgia $184M AUM 16.06% 1-Year Est. Return
NAM
Nutshell Asset Management Sevenoaks, United Kingdom $184M AUM 2.02% 1-Year Est. Return
GCGM
General Catalyst Group Management Cambridge, Massachusetts $184M AUM 50.45% 1-Year Est. Return
PSAMP
P. Schoenfeld Asset Management (PSAM) New York $184M AUM 97.09% 1-Year Est. Return
GCA
GSI Capital Advisors Newport Beach, California $184M AUM 5.17% 1-Year Est. Return
IVGAV
Index Venture Growth Associates V St. Helier, Jersey $184M AUM

Monashee Investment Management's Q1 2021 Portfolio in Review

As of Q1 2021, Monashee Investment Management held 529 positions worth $650M, down 14% from $757M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Monashee Investment Management withdrew a net $73.7M in Q1 2021, closing 155 positions and reducing 22 holdings. Its most notable exit was Sigilon Therapeutics, Inc. Common Stock, an estimated $27M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, down from 30% a quarter earlier, followed by Financials and Technology.

Against the trend, Monashee Investment Management opened a new position in Beam Therapeutics worth $21.5M.

  • Monashee Investment Management's largest Q1 2021 buy was Beam Therapeutics: 268,820 shares worth $21.5M.
  • Monashee Investment Management added most to View, Inc. Class A Common Stock in Q1 2021, an estimated $11.9M increase.
  • Monashee Investment Management's biggest Q1 2021 reduction was Vanguard Morningstar Total Stock Market ETF, cutting an estimated $53.1M.
  • Monashee Investment Management fully exited Sigilon Therapeutics, Inc. Common Stock in Q1 2021, selling an estimated $27M.
  • Monashee Investment Management's ten largest holdings make up 28% of its $650M portfolio in Q1 2021.
  • Monashee Investment Management opened 249 new positions and closed 155 in Q1 2021.
  • Monashee Investment Management's portfolio value fell 14% quarter-over-quarter to $650M.

Based on Monashee Investment Management's 13F filing for Q1 2021, filed 14 May 2021.